Article
Acute granulomatous interstitial nephritis in a patient with metastatic melanoma on targeted therapy with dabrafenib and trametinib-A case report.
Cancer reports (Hoboken, N.J.) - 1 Jul 2022
Krelle Anna, Mathai Vinod Kalapurackal, Kirkland Geoff, Nott Louise, Jose Matthew D, Whale Karen
Abstract excerpt
BACKGROUND: Combination molecular targeted therapy with dabrafenib plus trametinib has been shown to improve progression-free survival and overall survival in patients with BRAF V600 mutated unresectable or metastatic melanoma. In general, these agents are well tolerated. Kidney related adverse events are uncommon with only three case reports of acute interstitial nephritis and one case of a serious acute kidney...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
